Skip to main content

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease.

Publication ,  Journal Article
Waterman, M; Xu, W; Dinani, A; Steinhart, AH; Croitoru, K; Nguyen, GC; McLeod, RS; Greenberg, GR; Cohen, Z; Silverberg, MS
Published in: Gut
March 2013

OBJECTIVE: Previous investigations of short-term outcomes after preoperative exposure to biological therapy in inflammatory bowel disease (IBD) were conflicting. The authors aimed to assess postoperative outcomes in patients who underwent abdominal surgery with recent exposure to anti-tumour necrosis factor therapy. DESIGN: A retrospective case-control study with detailed matching was performed for subjects with IBD with and without exposure to biologics within 180 days of abdominal surgery. Postoperative outcomes were compared between the groups. RESULTS: 473 procedures were reviewed consisting of 195 patients with exposure to biologics and 278 matched controls. There were no significant differences in most postoperative outcomes such as: length of stay, fever (≥ 38.5°C), urinary tract infection, pneumonia, bacteraemia, readmission, reoperations and mortality. On univariate analysis, procedures on biologics had more wound infections compared with controls (19% vs 11%; p=0.008), but this was not significant in multivariate analysis. Concomitant therapy with biologics and thiopurines was associated with increased frequencies of urinary tract infections (p=0.0007) and wound infections (p=0.0045). Operations performed ≤ 14 days from last biologic dose had similar rates of infections and other outcomes when compared with those performed within 15-30 days or 31-180 days. Patients with detectable preoperative infliximab levels had similar rates of wound infection compared with those with undetectable levels (3/10 vs 0/9; p=0.21). CONCLUSION: Preoperative treatment with TNF-α antagonists in patients with IBD is not associated with most early postoperative complications. A shorter time interval from last biological dose is not associated with increased postoperative complications. In most cases, surgery should not be delayed, and appropriate biological therapy may be continued perioperatively.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gut

DOI

EISSN

1468-3288

Publication Date

March 2013

Volume

62

Issue

3

Start / End Page

387 / 394

Location

England

Related Subject Headings

  • Young Adult
  • Wound Infection
  • Urinary Tract Infections
  • Tumor Necrosis Factor-alpha
  • Treatment Outcome
  • Retrospective Studies
  • Preoperative Period
  • Postoperative Complications
  • Male
  • Length of Stay
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Waterman, M., Xu, W., Dinani, A., Steinhart, A. H., Croitoru, K., Nguyen, G. C., … Silverberg, M. S. (2013). Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut, 62(3), 387–394. https://doi.org/10.1136/gutjnl-2011-301495
Waterman, Matti, Wei Xu, Amreen Dinani, A Hillary Steinhart, Kenneth Croitoru, Geoffrey C. Nguyen, Robin S. McLeod, Gordon R. Greenberg, Zane Cohen, and Mark S. Silverberg. “Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease.Gut 62, no. 3 (March 2013): 387–94. https://doi.org/10.1136/gutjnl-2011-301495.
Waterman M, Xu W, Dinani A, Steinhart AH, Croitoru K, Nguyen GC, et al. Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut. 2013 Mar;62(3):387–94.
Waterman, Matti, et al. “Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease.Gut, vol. 62, no. 3, Mar. 2013, pp. 387–94. Pubmed, doi:10.1136/gutjnl-2011-301495.
Waterman M, Xu W, Dinani A, Steinhart AH, Croitoru K, Nguyen GC, McLeod RS, Greenberg GR, Cohen Z, Silverberg MS. Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut. 2013 Mar;62(3):387–394.

Published In

Gut

DOI

EISSN

1468-3288

Publication Date

March 2013

Volume

62

Issue

3

Start / End Page

387 / 394

Location

England

Related Subject Headings

  • Young Adult
  • Wound Infection
  • Urinary Tract Infections
  • Tumor Necrosis Factor-alpha
  • Treatment Outcome
  • Retrospective Studies
  • Preoperative Period
  • Postoperative Complications
  • Male
  • Length of Stay